Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-05-000090
Filing Date
2005-02-03
Accepted
2005-02-03 15:33:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 IMUNICON SCHEDULE 13G s13g_0202-2005immunicon.txt SC 13G 11791
  Complete submission text file 0000904454-05-000090.txt   13068
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 3401 MASONS MILL RD SUITE 100 HUNTINGTON VALLEY PA 19006 215 830 0777 X121
IMMUNICON CORP (Subject) CIK: 0001083132 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-80333 | Film No.: 05573183
SIC: 3826 Laboratory Analytical Instruments